These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3803679
1. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice]. Qureshi IA, Letarte J, Lebel S, Ouellet R. Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679 [Abstract] [Full Text] [Related]
2. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice. Gushiken T, Yoshimura N, Saheki T. Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843 [Abstract] [Full Text] [Related]
3. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase. Nelson J, Qureshi IA, Vasudevan S, Sarma DS. Chem Biol Interact; 1993 Oct; 89(1):35-47. PubMed ID: 8221965 [Abstract] [Full Text] [Related]
4. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. Hauser ER, Finkelstein JE, Valle D, Brusilow SW. N Engl J Med; 1990 Jun 07; 322(23):1641-5. PubMed ID: 2342523 [Abstract] [Full Text] [Related]
5. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Maestri NE, Lord C, Glynn M, Bale A, Brusilow SW. Medicine (Baltimore); 1998 Nov 07; 77(6):389-97. PubMed ID: 9854602 [Abstract] [Full Text] [Related]
6. Study of enzyme defect in a case of ornithine transcarbamylase deficiency. Qureshi IA, Letarte J, Quellet R. Diabete Metab; 1978 Dec 07; 4(4):239-41. PubMed ID: 729890 [Abstract] [Full Text] [Related]
7. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. Moscioni D, Morizono H, McCarter RJ, Stern A, Cabrera-Luque J, Hoang A, Sanmiguel J, Wu D, Bell P, Gao GP, Raper SE, Wilson JM, Batshaw ML. Mol Ther; 2006 Jul 07; 14(1):25-33. PubMed ID: 16677864 [Abstract] [Full Text] [Related]
8. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene. Saheki T, Mori K, Kobayashi K, Horiuchi M, Shige T, Obara T, Suzuki S, Mori M, Yamamura K. Biochim Biophys Acta; 1995 Jan 25; 1270(1):87-93. PubMed ID: 7827141 [Abstract] [Full Text] [Related]
9. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes. Marini JC, Erez A, Castillo L, Lee B. Am J Physiol Endocrinol Metab; 2007 Dec 25; 293(6):E1764-71. PubMed ID: 17925451 [Abstract] [Full Text] [Related]
10. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase]. Stoll C, Bieth R, Dreyfus J, Flori E, Lutz P, Levy JM. Arch Fr Pediatr; 1978 May 25; 35(5):512-8. PubMed ID: 678030 [Abstract] [Full Text] [Related]
11. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Ahrens MJ, Berry SA, Whitley CB, Markowitz DJ, Plante RJ, Tuchman M. Am J Med Genet; 1996 Dec 18; 66(3):311-5. PubMed ID: 8985493 [Abstract] [Full Text] [Related]
12. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency. Qureshi IA, Lebel S, Letarte J. Biochem Int; 1989 Sep 18; 19(3):657-66. PubMed ID: 2818615 [Abstract] [Full Text] [Related]
13. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Batshaw ML, Yudkoff M, McLaughlin BA, Gorry E, Anegawa NJ, Smith IA, Hyman SL, Robinson MB. Gene Ther; 1995 Dec 18; 2(10):743-9. PubMed ID: 8750014 [Abstract] [Full Text] [Related]
14. Heterogeneity of patients with late onset ornithine transcarbamylase deficiency. Tuchman M, Holzknecht RA. Clin Invest Med; 1991 Aug 18; 14(4):320-4. PubMed ID: 1782729 [Abstract] [Full Text] [Related]
15. The role of hepatic ornithine transcarbamylase deficiency in the orotic aciduria of pregnant mice. Qureshi IA, Letarte J, Tuchweber B, Yousef I, Qureshi SR. Eur J Obstet Gynecol Reprod Biol; 1986 Jul 18; 22(3):183-91. PubMed ID: 3732588 [Abstract] [Full Text] [Related]
16. Significance of transported glycine in the conjugation of sodium benzoate in spf mutant mice with ornithine transcarbamylase deficiency. Qureshi I, Rouleau T, Letarte J, Ouellet R. Biochem Int; 1986 Jun 18; 12(6):839-46. PubMed ID: 3091026 [Abstract] [Full Text] [Related]
17. Immunochemical analysis of carbamyl phosphate synthetase I and ornithine transcarbamylase deficient livers: elevated N-acetylglutamate level in a liver lacking carbamyl phosphate synthetase protein. Zhang W, Holzknecht RA, Butkowski RJ, Tuchman M. Clin Invest Med; 1990 Aug 18; 13(4):183-8. PubMed ID: 2208834 [Abstract] [Full Text] [Related]
18. Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene. Shimada T, Tashiro M, Kanzaki T, Noda T, Murakami T, Takiguchi M, Mori M, Yamamura K, Saheki T. J Dermatol Sci; 1994 Jul 18; 7 Suppl():S27-32. PubMed ID: 7999674 [Abstract] [Full Text] [Related]
19. Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease. Qureshi IA, Letarte J, Ouellet R. Pediatr Res; 1979 Jul 18; 13(7):807-11. PubMed ID: 481951 [No Abstract] [Full Text] [Related]
20. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. Nagasaka H, Yorifuji T, Egawa H, Kikuta H, Tanaka K, Kobayashi K. J Pediatr; 2001 Mar 18; 138(3):432-4. PubMed ID: 11241058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]